Meeder Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
VA
HIG
Meeder Asset Management's NVAX Position: Q4 2022 in Review
Meeder Asset Management sold out of Novavax (NVAX) in Q4 2022, closing a stake of 20 shares.
Meeder Asset Management first reported a position in NVAX in Q4 2016 and held it in 19 quarters. The position peaked at $485K in Q2 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.
- Meeder Asset Management reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
- Meeder Asset Management sold 20 Novavax shares in Q4 2022.
- Meeder Asset Management first reported a position in Novavax in Q4 2016 and held it in 19 quarters.
- Meeder Asset Management's Novavax position peaked at $485K in Q2 2021.
- 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.
Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.